A digital approach to building better peptides

Solid-phase peptide synthesis is a well established process that’s used to manufacture peptides for both clinical development and commercial supply. Currently available technologies, however, are prone to errors and may not provide all the answers that modern formulators need. Dr Kevin Robinson (KSR) recently caught up with Almac’s Steve McIntyre (SM), Manager, Peptide Process Development, to discuss a novel solution that takes a digitalisation approach to overcoming these hurdles.